Dorman Products (DORM) awards director 1,344 restricted stock units

Rhea-AI Filing Summary

Dorman Products, Inc. director John J. Gavin reported an equity compensation grant. He acquired 1,344 restricted stock units representing a contingent right to receive Dorman common shares, valued at $122.71 per unit. Following this award, his direct holdings total 10,546 shares.

The restricted stock units will vest in full on the earlier of the first anniversary of the grant date or the date of the company’s next annual meeting of shareholders, aligning director compensation with long-term shareholder outcomes.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider GAVIN JOHN J

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,344	$122.71	$165K

Holdings After Transaction: Common Stock — 10,546 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted stock units granted: 1,344 units Grant valuation price: $122.71 per unit Holdings after grant: 10,546 shares +1 more

4 metrics

Restricted stock units granted 1,344 units Equity award to director John J. Gavin

Grant valuation price $122.71 per unit Reference value for restricted stock unit grant

Holdings after grant 10,546 shares Total direct Dorman common shares held post-transaction

Vesting condition Earlier of first anniversary or next annual meeting Full vesting trigger for restricted stock units

Key Terms

restricted stock units, contingent right, annual meeting of shareholders, director

4 terms

restricted stock units financial

"Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"restricted stock units representing a contingent right to receive shares of Dorman common stock."

annual meeting of shareholders financial

"vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

director financial

"GAVIN JOHN J is reported as a director of Dorman Products, Inc."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GAVIN JOHN J

(Last) (First) (Middle)

C/O DORMAN PRODUCTS, INC.

3400 EAST WALNUT STREET

(Street)

COLMAR PENNSYLVANIA 18915

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Dorman Products, Inc. [ DORM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		A		1,344(1)	A	$122.71	10,546	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.

	/s/ Frank J. Mahr, by Power of Attorney	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Dorman Products (DORM) report for John J. Gavin?

Dorman Products reported that director John J. Gavin received 1,344 restricted stock units as an equity award. These units represent a contingent right to receive common shares and form part of his director compensation package.

How many Dorman Products (DORM) shares does John J. Gavin hold after this grant?

After the equity grant, John J. Gavin’s direct holdings total 10,546 Dorman Products common shares. This figure reflects his position following receipt of 1,344 restricted stock units awarded on the reported grant date.

At what price were John J. Gavin’s Dorman Products (DORM) restricted stock units valued?

The 1,344 restricted stock units granted to John J. Gavin were valued at $122.71 per unit. This reference price helps quantify the size of the director’s compensation-related equity award in this Form 4 filing.

When do John J. Gavin’s Dorman Products (DORM) restricted stock units vest?

The restricted stock units will vest in full on the earlier of the first anniversary of the grant date or the date of Dorman Products’ next annual meeting of shareholders, tying vesting to either time-based service or the upcoming shareholder event.

What does the Form 4 grant to John J. Gavin indicate about Dorman Products (DORM)?

The Form 4 shows Dorman Products using restricted stock units as director compensation. It highlights alignment of director incentives with shareholder value through equity awards that vest over time or at the next annual shareholder meeting.